The aflo™ platform combines a device, user co-designed App, clinician portal and a cloud-based, AI-driven data analytics tool with next-generation software to deliver real-time inhaler technique, symptoms and trigger identification. Platform design and testing are underway in 2021 with a final product available in 2022/23.